Table 1 shows the characteristics of the participants identified by a random ID and including gender (M=Male; F=Female), age, BMI, HbA1c, diabetes treatment (MDI: Multiples doses of insulin; CSII: Continuous subcutaneous insulin infusion), and years of evolution of T1DM. This evidence concerns the gene INS and diabetes mellitus.